ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664W905. A total of 3 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $46,000 | -96.8% | 100 | -73.0% | 0.01% | -96.9% |
| Q2 2018 | $1,450,000 | -81.4% | 370 | -65.6% | 0.22% | -51.8% |
| Q1 2018 | $7,782,000 | +928.0% | 1,076 | +835.7% | 0.46% | +573.9% |
| Q4 2017 | $757,000 | -33.0% | 115 | -64.1% | 0.07% | +13.1% |
| Q1 2017 | $1,130,000 | +35.7% | 320 | +55.3% | 0.06% | +134.6% |
| Q4 2014 | $833,000 | – | 206 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 370 | $1,450,000 | 0.22% |
| Pentwater Capital Management LP | 60,000 | $2,351,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 23,900 | $937,000 | 0.01% |
| SIMPLEX TRADING, LLC | 139 | $544,000 | 0.00% |
| American Portfolios Advisors | 22 | $17,420 | 0.00% |
| JPMORGAN CHASE & CO | 84,000 | $3,292,000 | 0.00% |